Effect of LCZ696 and Its Components Sacubitril and Valsartan on Insulin Secretion and Glucose Homeostasis in Mice

被引：0
|
作者：
Esser, Nathalie
Schmidt, Christine R.
Barrow, Breanne
Cronic, Laura
Hackney, Daryl J.
Mongovin, Steve M.
Hull, Rebecca L.
Zraika, Sakeneh
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-1797-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1797-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects
    Akahori, Mizuki
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Zhou, Wei
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (03) : 407 - 416
  • [42] Pharmacokinetics After Single Ascending Dose, Food Effect, and Safety of Sacubitril/Valsartan (LCZ696), an Angiotensin Receptor and Neprilysin Inhibitor, in Healthy Japanese Subjects
    Mizuki Akahori
    Surya Ayalasomayajula
    Thomas Langenickel
    Parasar Pal
    Wei Zhou
    Gangadhar Sunkara
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 407 - 416
  • [43] The neuroprotective effect of LCZ696 on methamphetamine-induced cognitive impairment in mice
    Qian, Liyin
    Ruan, Yuer
    Gong, Xinshuang
    Yu, Zhaoying
    Lin, Shujun
    Li, Xiaofang
    Shen, Yao
    Luo, Hu
    Si, Zizhen
    Liu, Yu
    NEUROSCIENCE LETTERS, 2024, 823
  • [44] Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens
    Senni, Michele
    McMurray, John J. V.
    Wachter, Rolf
    McIntyre, Hugh F.
    Reyes, Antonio
    Majercak, Ivan
    Andreka, Peter
    Shehova-Yankova, Nina
    Anand, Inder
    Yilmaz, Mehmet B.
    Gogia, Harinder
    Martinez-Selles, Manuel
    Fischer, Steffen
    Zilahi, Zsolt
    Cosmi, Franco
    Gelev, Valeri
    Galve, Enrique
    Gomez-Doblas, Juanjo J.
    Nociar, Jan
    Radomska, Maria
    Sokolova, Beata
    Volterrani, Maurizio
    Sarkar, Arnab
    Reimund, Bernard
    Chen, Fabian
    Charney, Alan
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (09) : 1193 - 1202
  • [45] LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD
    Jing, Wanghui
    Vaziri, Nosratola D.
    Nunes, Ane
    Suematsu, Yasunori
    Farzaneh, Ted
    Khazaeli, Mahyar
    Moradi, Hamid
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (12): : 5473 - 5484
  • [46] Evaluation of Drug-Drug Interaction Potential Between Sacubitril/Valsartan (LCZ696) and Statins Using a Physiologically Based Pharmacokinetic Model
    Lin, Wen
    Ji, Tao
    Einolf, Heidi
    Ayalasomayajula, Surya
    Lin, Tsu-Han
    Hanna, Imad
    Heimbach, Tycho
    Breen, Christopher
    Jarugula, Venkateswar
    He, Handan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (05) : 1439 - 1451
  • [47] AHU377+VALSARTAN (LCZ696) MODULATES RAS COMPONENTS IN THE CARDIAC AND AORTA OF FEMALE SPONTANEOUSLY HYPERTENSIVE RATS COMPARED WITH VALSARTAN
    Yang, Zhao
    Ma, RuiXin
    Yu, Xiaorong
    Li, Ningyin
    Yu, Heng
    Zhao, Xu
    Xu, Han
    Yuan, Ruowen
    Zhang, Xiaowei
    Liang, Wei
    Yu, Jing
    JOURNAL OF HYPERTENSION, 2018, 36 : E14 - E14
  • [48] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor (vol 56, pg 1461, 2017)
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 105 - 123
  • [49] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
    Ademi, Z.
    Hancock, E.
    Trueman, D.
    Pfeil, A.
    Haroun, R.
    Deschaseaux, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [50] Evaluation of Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Sacubitril/Valsartan (LCZ696) and Sildenafil in Patients With Mild-to-Moderate Hypertension
    Hsiao, H-L
    Langenickel, T. H.
    Petruck, J.
    Kode, K.
    Ayalasomayajula, S.
    Schuehly, U.
    Greeley, M.
    Pal, P.
    Zhou, W.
    Prescott, M. F.
    Sunkara, G.
    Rajman, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (03) : 468 - 476
12345